The genito-urinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, reno vascular diseases, benign prostate diseases, and other related diseases.
The global genito-urinary drugs market was valued at around $60 billion in 2017. North America was the largest region in the genito-urinary drugs market in 2017, accounting for under 39% market share. The USA was the largest country in the market in 2017, accounting for above 30% market share.
The launch of combination products for the treatment of urinary tract infections is an emerging trend in the genito-urinary disorder drugs market. Competitors in the market are developing combination drugs to fight multi-drug resistant bacteria and also expanding indications for existing drugs for the treatment of genito-urinary disorders.
The top five companies covered are Daiichi Sankyo Company, Limited Pfizer Inc., Bayer AG, Astellas Pharma Inc, and Allergan Plc. Daiichi Sankyo was the largest company in the genito-urinary drugs market in 2017.
The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.
The genito-urinary drugs market is segmented into Hormonal Contraceptives, Drugs For Hormonal Replacement Therapy, Drugs For Infections And Others, Drugs for Benign Prostatic Hypertrophy, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs for Infertility, and Diuretics.
Hormonal Contraceptives segment includes organizations that manufacture medicines that act on the endocrine system and prevent pregnancy.
Drugs For Hormonal Replacement Therapy segment includes organizations that manufacture drugs that are used for the treatment used to relieve the symptoms of menopause.
Drugs For Infections And Others segment includes drugs for urinary tract infections, chlamydial infections, pyelonephritis, cystitis, leptospirosis, ulceration of the vulva, vaginitis and others.
Drugs for Benign Prostatic Hypertrophy - benign prostatic hypertrophy is the enlargement of the prostate gland that causes urination difficulty.
Drugs For Erectile Dysfunction - erectile dysfunction, also known as impotence, is a sexual dysfunction in which the ability to develop or maintain an erection of the penis during sexual activity is lost.
Drugs For Urinary Incontinence And Overactive Bladder - urinary incontinence and overactive bladder is the involuntary leakage of urine due to weakened or complete loss of control over the urinary sphincter.
Drugs for Infertility - infertility is defined as not being able to conceive due to reasons which may include inadequate hormone levels in men and women, ovulation problem in women.
Diuretics are medicines that promote increased production of urine.